CM
CORZ icon

Caption Management’s Core Scientific CORZ Stock Holding History

Caption Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-71,086
Closed -$1.04M – 1720
2025
Q2 		$1.21M Buy
+71,086
New +$711K 0.01% 882
2024
Q4 		– Sell
-35,400
Closed -$523K – 1514
2024
Q3 		$420K Buy
+35,400
New +$367K 0.01% 955

Other funds holding CORZ

SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Caption Management's CORZ Position: Q3 2025 in Review

Caption Management sold out of Core Scientific (CORZ) in Q3 2025, closing a stake of 71,086 shares — an estimated $1.04M sold.

Caption Management first reported a position in CORZ in Q3 2024 and held it in 2 quarters. The position peaked at $1.21M in Q2 2025. 336 funds tracked by Wall St. Rank hold CORZ as of Q3 2025.

  • Caption Management reported no remaining Core Scientific position as of Q3 2025 after selling out during the quarter.
  • Caption Management sold 71,086 Core Scientific shares in Q3 2025, an estimated $1.04M.
  • Caption Management first reported a position in Core Scientific in Q3 2024 and held it in 2 quarters.
  • Caption Management's Core Scientific position peaked at $1.21M in Q2 2025.
  • 336 funds tracked by Wall St. Rank held Core Scientific as of Q3 2025.

Based on Caption Management's 13F filing for Q3 2025, filed 14 Nov 2025.